1. Home
  2. AXDX vs SURG Comparison

AXDX vs SURG Comparison

Compare AXDX & SURG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AXDX
  • SURG
  • Stock Information
  • Founded
  • AXDX 1982
  • SURG 2006
  • Country
  • AXDX United States
  • SURG United States
  • Employees
  • AXDX N/A
  • SURG N/A
  • Industry
  • AXDX Biotechnology: Laboratory Analytical Instruments
  • SURG Advertising
  • Sector
  • AXDX Industrials
  • SURG Consumer Discretionary
  • Exchange
  • AXDX Nasdaq
  • SURG Nasdaq
  • Market Cap
  • AXDX 13.7M
  • SURG 27.0M
  • IPO Year
  • AXDX 1996
  • SURG N/A
  • Fundamental
  • Price
  • AXDX $0.14
  • SURG $2.78
  • Analyst Decision
  • AXDX
  • SURG Strong Buy
  • Analyst Count
  • AXDX 0
  • SURG 1
  • Target Price
  • AXDX N/A
  • SURG $8.75
  • AVG Volume (30 Days)
  • AXDX 425.6K
  • SURG 289.4K
  • Earning Date
  • AXDX 05-16-2025
  • SURG 05-20-2025
  • Dividend Yield
  • AXDX N/A
  • SURG N/A
  • EPS Growth
  • AXDX N/A
  • SURG N/A
  • EPS
  • AXDX N/A
  • SURG N/A
  • Revenue
  • AXDX $11,698,000.00
  • SURG $60,881,173.00
  • Revenue This Year
  • AXDX $7.25
  • SURG $59.57
  • Revenue Next Year
  • AXDX N/A
  • SURG $75.47
  • P/E Ratio
  • AXDX N/A
  • SURG N/A
  • Revenue Growth
  • AXDX N/A
  • SURG N/A
  • 52 Week Low
  • AXDX $0.12
  • SURG $1.05
  • 52 Week High
  • AXDX $2.09
  • SURG $4.38
  • Technical
  • Relative Strength Index (RSI)
  • AXDX 14.62
  • SURG 56.98
  • Support Level
  • AXDX $0.50
  • SURG $2.56
  • Resistance Level
  • AXDX $0.56
  • SURG $3.47
  • Average True Range (ATR)
  • AXDX 0.05
  • SURG 0.28
  • MACD
  • AXDX -0.01
  • SURG -0.07
  • Stochastic Oscillator
  • AXDX 4.44
  • SURG 35.51

About AXDX Accelerate Diagnostics Inc.

Accelerate Diagnostics Inc is an in vitro diagnostics company dedicated to providing solutions that improve patient outcomes and lower healthcare costs through the rapid diagnosis of serious infections. Its Clinical Microbiology products include Accelerate Pheno system, Accelerate PhenoTest BC Kit, and Accelerate Arc module & BC kit. The company earns the majority of its revenue from the domestic market. The group operates as one operating segment, deriving instrument, consumable, and service revenues from customers engaged in healthcare diagnostics within the United States. Product revenue is derived from the sale or rental of instruments and sales of related consumable products. Service revenue is derived from the sale of extended service agreements.

About SURG SurgePays Inc.

Surgepays Inc is a fintech company focused on the underbanked community. It provides services to financial technology, telecommunications, and digital media companies. Its operating segment includes Mobile Virtual Network Operators that provide mobile broadband (internet connectivity), voice and SMS text messaging to both subsidized and direct retail prepaid customers through SurgePhone Wireless, LLC and Torch Wireless, LLC; Comprehensive Platform Services provide financial technology and a wireless top-up platform to independently owned convenience stores throughout the country; Lead Generation is a generation and case management solutions company serving law firms in the mass tort industry; and Others. It generates the revenue from Mobile Virtual Network Operator segment.

Share on Social Networks: